Yeah VP does talk fast but I still managed 2.0X - of course my head exploded but there's not much to clean up.
I also noted Makary responded to a question with reiteration that Accelerated/Priority Reviews would be maintained as they're a success and will be built upon so that's good - he remarked similarly in the round table. He's clearly heard the anxiety in the industry after previous comments and has been at pains to calm the pharm.
MSB Price at posting:
$1.76 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)